0001213900-17-007563.txt : 20170714 0001213900-17-007563.hdr.sgml : 20170714 20170714132543 ACCESSION NUMBER: 0001213900-17-007563 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170714 DATE AS OF CHANGE: 20170714 EFFECTIVENESS DATE: 20170714 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hoth Therapeutics, Inc. CENTRAL INDEX KEY: 0001711786 IRS NUMBER: 821553794 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-290781 FILM NUMBER: 17965214 BUSINESS ADDRESS: STREET 1: 1 ROCKEFELLER PLAZA, SUITE 1039 CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 551-578-2261 MAIL ADDRESS: STREET 1: 1 ROCKEFELLER PLAZA, SUITE 1039 CITY: NEW YORK STATE: NY ZIP: 10020 D 1 primary_doc.xml X0707 D LIVE 0001711786 Hoth Therapeutics, Inc. 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY NEW YORK 10020 (551) 578-2661 NEVADA None None Corporation true 2017 ROBB KNIE 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY NEW YORK 10020 Executive Officer Promoter VADIM MATS 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY NEW YORK 10020 Director KENNETH RICE 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY NEW YORK 10020 Director ANTHONY HAYES 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY NEW YORK 10020 Director Pharmaceuticals Decline to Disclose 06b false 2017-06-30 false true false 675000 675000 675000 0 false 1 0 0 0 true In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false Hoth Therapeutics, Inc. /s/ Robb Knie Robb Knie CEO 2017-07-12